OriCiro Genomics
OriCiro Genomics develops and commercializes cell-free synthesis and amplification technologies of large DNA molecules.
OriCiro Genomics operates in biotechnology, genetics, health care, life science based in Asia-Pacific (APAC), founded in 2018.
The company sits in the biotechnology, genetics, health care, life science segment, where it competes on its core product or service.
The company is recorded as being based in Asia-Pacific (APAC).
Its current recorded stage is Series_B.
Recorded headcount: c_00001_00010 employees.
It has disclosed roughly $12.7M in funding.
| Sector | Biotechnology, Genetics, Health Care, Life Science |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2018 |
| Employees | c_00001_00010 |
| Stage | series_b |
| Total funding | $12,697,525 |
Website: oriciro.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account